FDA Says Compounding Pharmacies Can Keep Making Weight-Loss Med Tirzepatide, for Now
TUESDAY, Oct. 15, 2024 (HealthDay News) -- Pharmacists may continue making compounded versions of the weight-loss medication ...
Seasoned Seaweed Recalled Over Allergy Fears
Packets of Korean seasoned seaweed are being recalled after a packaging mix-up that meant sesame was not declared on the ...
Delta cancels meal service on more than 200 Detroit flights over food safety issue
Delta scrapped meal service from hundreds of flights over weekend due to safety issue at food production facility.
US FDA clears CMR Surgical's robotic device to assist gall bladder removal
UK-based medical device maker CMR Surgical said on Tuesday that the U.S. Food and Drug Administration has cleared the ...
Medscape12h
FDA Approves Fifth Ustekinumab Biosimilar
The drug is approved for multiple inflammatory conditions and is expected to launch in the first half of 2025.
Major Airline Cancels Meal Service After FDA Flags ‘Food Safety Issue'
A major airline was forced to cancel meal service on hundreds of flights after the Food and Drug Administration (FDA) ...
Coca-Cola recalls ‘zero sugar’ lemonade after it’s found to contain full sugar
Coca-Cola has recalled thousands of cans of Minute Maid Zero Sugar Lemonade that were improperly labeled and actually ...
The Motley Fool8h
Should Eli Lilly Investors Worry About This Unexpected FDA Move?
The FDA earlier this month recognized Lilly’s progress in increasing supply and took the drug off the agency’s shortage list.
Drugmakers can keep making off-brand weight-loss drugs as FDA backpedals
Facing a lawsuit, the Food and Drug Administration has decided to reconsider its decision to take popular weight-loss and diabetes drugs off of the national shortage list, which will allow compounding ...
Pharmaceutical Technology52m
FDA accepts UroGen’s UGN-102 NDA for bladder cancer treatment
UroGen Pharma has received the NDA acceptance from the US FDA for UGN-102 (mitomycin) to treat bladder cancer.
WPTV-TV11h
FDA is reconsidering its decision to take tirzepatide off its drug shortage list
Pharmacists can continue making compounded versions of generic tirzepatide, the active ingredient in popular medications ...
Experimental ALS drug could offer new hope for patients if approved, researchers say
New hope could be on the horizon for ALS patients in the form of a “breakthrough" drug, researchers say. Neuvivo is seeking approval for an experimental medication for the neurological condition.